Efficacy And Safety Of Decitabine Combined With Low-Dose Cytarabine, Aclarubicin, And Granulocyte Colony-Stimulating Factor Compared With Standard Therapy In Acute Myeloid Leukemia Patients With Tp53 Mutation
CHINESE MEDICAL JOURNAL（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined